Neo-antigen DC vaccine(Sichuan Univ)

N/A

Report date: 2025/01/26 17:36:24

Base Information

Drug NameNeo-antigen DC vaccine(Sichuan Univ)

Drug Alias Nametumor antigen-sensitized dendritic cells vaccine (Sichuan Univ)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapyBiologics > Antigen > Tumor antigenVaccines > Application > Therapeutic vaccine +[4]

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsEsophageal NeoplasmsCarcinoma, Squamous Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesSichuan University

China Registration ClassN/A

Develop Information

Active CompaniesSichuan University

Inactive CompaniesN/A

Active IndicationsEsophageal NeoplasmsCarcinoma, Squamous Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A